The safety and efficacy of transcutaneous carbon dioxide (CO2) application for malignant bone and soft tissue tumor (sarcoma)
Not Applicable
Recruiting
- Conditions
- Malignant bone and soft tissue tumor Sarcoma
- Registration Number
- JPRN-UMIN000029101
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Skin ulcer or pathological fracture in the treated area (2) Peripheral arterial disease or ischemic disease in the affected limb (3) Skin disease in the affected limb (4) Active infectious disease in the affected limb (5) Other medical or psychological unsuitable reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complication
- Secondary Outcome Measures
Name Time Method antitumor effect local blood flow